- Home
- Supplements
- Vitamin D
- Autoimmune Disease
Vitamin D for Autoimmune Disease
Vitamin D is the best-supported supplement across autoimmune conditions: the VITAL trial found 2000 IU daily reduced new autoimmune diagnoses over five years, and deficiency is near-universal in people with established disease. It is a foundation, not a treatment — disease-modifying medication remains the thing that changes outcomes.
Overview
Verdict
Prevention signal in a major trial and near-universal deficiency worth correcting; modest effects once disease is established.
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 1000-2000 IU daily, adjusted to maintain a tested level; higher doses need monitoring.
- Expected timeframe
- Levels correct over 8-12 weeks; any clinical effect is a months-to-years horizon.
Protocol
- form
- Vitamin D3 (cholecalciferol)
- duration
- At least 2 years - the VITAL autoimmune outcome emerged over 5 years
- co factor
- Take with the largest meal. Evidence is mixed and the nuance is important: the VITAL randomised trial of 2000 IU/day found a roughly 22% reduction in incident autoimmune disease over five years, which is the best evidence there is for prevention. Evidence that vitamin D improves established autoimmune disease activity is much weaker and largely observational, confounded by the fact that illness itself lowers vitamin D levels.
- titration
- Aim for a 25-hydroxyvitamin D level of 75-125 nmol/L; the VITAL trial used 2000 IU/day
- starting dose
- 1000-2000 IU (25-50 mcg) vitamin D3 daily with a fat-containing meal, after checking 25-hydroxyvitamin D
Evidence
What the studies say
Vitamin D and the Immune System: New Perspectives on an Old Theme
Aranow C
Vitamin D receptors are expressed on monocytes, macrophages, dendritic cells and T and B lymphocytes; calcitriol upregulates antimicrobial peptides such as cathelicidin, dampens Th1/Th17 responses and promotes regulatory T cells. Deficiency is associated with autoimmune disease and infection risk in observational data.
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial
Hahn J, Cook NR, Alexander EK
Vitamin D reduced confirmed incident autoimmune disease by 22% (HR 0.78).
Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: a systematic review and meta-analysis
Franco AS, Freitas TQ, Bernardo WM
No consistent improvement in disease activity with vitamin D in autoimmune rheumatic disease.
Safety
Caveats
Essential rather than optional if you take corticosteroids, due to bone loss. Toxicity only at sustained high doses without monitoring. Does not replace disease-modifying treatment.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.